Literature DB >> 8812512

One-Session Management of Cervical Intraepithelial Neoplasia: A Solution for Developing Countries. A Prospective, Randomized Trial of LEEP versus Laser Excisional Conization

.   

Abstract

Six hundred thirty-nine patients with CIN on referral Pap were evaluated cytocolposcopically at the first visit and decided whether to be treated the same day or not. One hundred ninety-two patients (30%) were considered negative. Follow-up evidenced later appearance of CIN in five of them. One hundred fifty-three (24%) were candidates for delayed treatment due to conditions contraindicating same-day treatment. Two hundred ninety-four patients (46%) were randomly allocated in LEEP (149) or excisional laser (145) arms, and treated the same day under local anesthesia. Both arms were comparable. There were three microinvasive carcinomas diagnosed in the surgical specimen. LEEP was faster and produced less bleeding than laser, although required a mean of four slices to remove the lesion. Arterial hypertension after anesthetic infiltration was detected in 26% of cases. Two intraoperative and two delayed bleeders required surgery. The size of lesion and surgical defect were larger than those reported in the literature. Margins were involved in 8 patients (2.7%). Only 4.7% (7/149) of patients randomized to LEEP and 3.4% (5/145) with excisional laser had persistent or recurrent CIN on follow-up. Factors predisposing to failure included depth of surgical defect, grade of lesion, and operator's expertise. With this approach, 69% of patients referred for cytology of CIN were adequately managed in the first visit, which contrasts to classical management that reaches the state of treatment in 30% of patients. LEEP appears to be faster, less costly, and requires less expertise. Its use in conjunction with adequate screening is recommended for developing countries.

Entities:  

Year:  1996        PMID: 8812512

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

Review 1.  Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review.

Authors:  Eric Chamot; Sibylle Kristensen; Jeffrey S A Stringer; Mulindi H Mwanahamuntu
Journal:  BMC Womens Health       Date:  2010-04-01       Impact factor: 2.809

2.  Treatment of the patients with abnormal cervical cytology: a "see-and-treat" versus three-step strategy.

Authors:  Hanbyoul Cho; Jae-Hoon Kim
Journal:  J Gynecol Oncol       Date:  2009-09-30       Impact factor: 4.401

3.  'See-and-treat' works for cervical cancer prevention: what about controlling the high burden in India?

Authors:  R Sankaranarayanan
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

4.  Cervical cancer prevention program in Jakarta, Indonesia: See and Treat model in developing country.

Authors:  Laila Nuranna; Mohamad Farid Aziz; Santoso Cornain; Gatot Purwoto; Sigit Purbadi; Setyawati Budiningsih; Budiningsih Siregar; Alexander Arnold Willem Peters
Journal:  J Gynecol Oncol       Date:  2012-07-02       Impact factor: 4.401

5.  Predictors of persistent cytologic abnormalities after treatment of cervical intraepithelial neoplasia in Soweto, South Africa: a cohort study in a HIV high prevalence population.

Authors:  Yasmin Adam; Cyril J van Gelderen; Guy de Bruyn; James A McIntyre; Diane A Turton; Neil A Martinson
Journal:  BMC Cancer       Date:  2008-07-25       Impact factor: 4.430

6.  Cervical cancer screening: Safety, acceptability, and feasibility of a single-visit approach in Bulawayo, Zimbabwe.

Authors:  Muriel S Fallala; Robert Mash
Journal:  Afr J Prim Health Care Fam Med       Date:  2015-05-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.